Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Oze

Showing results (101-110 of 240) with videos related to

Pageof 24
Sort By:
Preventive Medicine Reports|July 16, 2016
Influence of cigarette smoking and inflammatory gene polymorphisms on glycated hemoglobin in the Japanese general populationYuichiro Nishida, Megumi Hara, Tatsuhiko Sakamoto, et al.
Maturitas|September 2, 2015
Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum sex hormone level among postmenopausal Japanese womenSatoyo Hosono, Hidemi Ito, Isao Oze, et al.
Diabetes Research and Clinical Practice|October 27, 2015
Association between brain-muscle-ARNT-like protein-2 (BMAL2) gene polymorphism and type 2 diabetes mellitus in obese Japanese individuals: A cross-sectional analysis of the Japan Multi-institutional Collaborative Cohort StudyMiwa Yamaguchi, Hirokazu Uemura, Kokichi Arisawa, et al.
Journal of Diabetes|September 17, 2015
Variant of the clock circadian regulator (CLOCK) gene and related haplotypes are associated with the prevalence of type 2 diabetes in the Japanese populationHirokazu Uemura, Sakurako Katsuura-Kamano, Miwa Yamaguchi, et al.
PPAR Research|November 30, 2013
Polymorphisms in PPAR Genes (PPARD, PPARG, and PPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC StudyAsahi Hishida, Kenji Wakai, Mariko Naito, et al.
Journal of Epidemiology|July 5, 2026
Serum Urate and Kidney Function in Japanese Cohorts: Mendelian Randomization and Biomarker-Dependent Associations of a URAT1 Loss-of-Function VariantKazushi Yasuda, Masahiro Nakatochi, Yuki Ohashi, et al.
Cancer Chemotherapy and Pharmacology|June 21, 2015
Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysisMotoo Nomura, Isao Oze, Tetsuya Abe, et al.
International Journal of Clinical Oncology|August 28, 2025
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapyNobuaki Ochi, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Clinical Oncology|May 9, 2022
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801Shinobu Hosokawa, Eiki Ichihara, Daijiro Harada, et al.
Journal of Epidemiology|August 7, 2012
DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiologyLian Li, Ji-Yeob Choi, Kyoung-Mu Lee, et al.
Pageof 24

Showing results (101-110 of 240) with videos related to

Sort By:
Pageof 24
Preventive Medicine Reports|July 16, 2016
Influence of cigarette smoking and inflammatory gene polymorphisms on glycated hemoglobin in the Japanese general populationYuichiro Nishida, Megumi Hara, Tatsuhiko Sakamoto, et al.
Maturitas|September 2, 2015
Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum sex hormone level among postmenopausal Japanese womenSatoyo Hosono, Hidemi Ito, Isao Oze, et al.
Diabetes Research and Clinical Practice|October 27, 2015
Association between brain-muscle-ARNT-like protein-2 (BMAL2) gene polymorphism and type 2 diabetes mellitus in obese Japanese individuals: A cross-sectional analysis of the Japan Multi-institutional Collaborative Cohort StudyMiwa Yamaguchi, Hirokazu Uemura, Kokichi Arisawa, et al.
Journal of Diabetes|September 17, 2015
Variant of the clock circadian regulator (CLOCK) gene and related haplotypes are associated with the prevalence of type 2 diabetes in the Japanese populationHirokazu Uemura, Sakurako Katsuura-Kamano, Miwa Yamaguchi, et al.
PPAR Research|November 30, 2013
Polymorphisms in PPAR Genes (PPARD, PPARG, and PPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC StudyAsahi Hishida, Kenji Wakai, Mariko Naito, et al.
Journal of Epidemiology|July 5, 2026
Serum Urate and Kidney Function in Japanese Cohorts: Mendelian Randomization and Biomarker-Dependent Associations of a URAT1 Loss-of-Function VariantKazushi Yasuda, Masahiro Nakatochi, Yuki Ohashi, et al.
Cancer Chemotherapy and Pharmacology|June 21, 2015
Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysisMotoo Nomura, Isao Oze, Tetsuya Abe, et al.
International Journal of Clinical Oncology|August 28, 2025
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapyNobuaki Ochi, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Clinical Oncology|May 9, 2022
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801Shinobu Hosokawa, Eiki Ichihara, Daijiro Harada, et al.
Journal of Epidemiology|August 7, 2012
DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiologyLian Li, Ji-Yeob Choi, Kyoung-Mu Lee, et al.
Pageof 24